MDL | - |
---|---|
Molecular Weight | 404.29 |
Molecular Formula | C12H14KN2O8V |
SMILES | O=[V+3]12([N]3=CC=C4)([O-][O-]1)([O-][O-]2)[N]5=C6C3=C4C=CC6=CC=C5.O.O.O.[K+] |
bpV(phen) trihydrate, a insulin-mimetic agent, is a potent protein tyrosine phosphatase (PTP) and PTEN inhibitor with IC 50 s of 38 nM, 343 nM and 920 nM for PTEN , PTP-β and PTP-1B , respectively. bpV(phen) trihydrate inhibits proliferation of the protozoan parasite Leishmania in vitro. bpV(phen) trihydrate strongly induces the secretion of a large number of chemokines and pro-inflammatory cytokines, and it activates a Th1-type pathway (IL-12, IFNγ). bpV(phen) trihydrate can also induce cell apoptosis , and has anti-angiogenic and anti-tumor activity [1] [2] [3] [4] [5] .
bpV(phen) (5 μM; 24.5 hours; H9c2 cells) treatment causes a further decrease of cell viability in H/R-injured H9c2 cells
[1]
.
bpV(phen) (5 μM; 24.5 hours; H9c2 cells) treatment increases the apoptosis of H/R-injured H9c2 cells
[1]
.
bpV(phen) (5 μM; 24.5 hours; H9c2 cells) treatment significantly promotes the accumulation of cytoplasmic Cytochrome C in H/R-injured H9c2 cells
[1]
.
After stimulation of bpV(phen), PTEN-induced putative kinase protein 1 (PINK1)/Parkin-mediated mitophagy is inhibited
[1]
.
bpV(phen) is an insulin-mimetic agent following insulin-receptor tyrosine kinase hyperphosphorylation and activation
[4]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Viability Assay [1]
Cell Line: | Hypoxia/reoxygenation (H/R)-injured H9c2 cells |
Concentration: | 5 μM |
Incubation Time: | 24.5 hours (hypoxia for 24 h; reoxygenation for 30 minutes) |
Result: | Caused a further decrease of cell viability. |
Apoptosis Analysis [1]
Cell Line: | Hypoxia/reoxygenation (H/R)-injured H9c2 cells |
Concentration: | 5 μM |
Incubation Time: | 24.5 hours (hypoxia for 24 h; reoxygenation for 30 minutes) |
Result: | Increased the apoptosis of H/R-injured H9c2 cells. |
Western Blot Analysis [1]
Cell Line: | Hypoxia/reoxygenation (H/R)-injured H9c2 cells |
Concentration: | 5 μM |
Incubation Time: | 24.5 hours (hypoxia for 24 h; reoxygenation for 30 minutes) |
Result: | Showed an increased release of Cytochrome C. |
bpV(phen) (5 mg/kg; intraperitoneal injection; daily; for 38 days; male BALB/c nude (nu/nu) athymic mice) treatment causes a significant reduction in average tumor volume [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: | Male BALB/c nude (nu/nu) athymic mice (6-7 weeks old) injected with PC-3 cells [2] |
Dosage: | 5 mg/kg |
Administration: | Intraperitoneal injection; daily; for 38 days |
Result: | Caused a significant reduction in average tumor volume. |
Solid
Room temperature in continental US; may vary elsewhere.
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
H 2 O : 18.18 mg/mL ( 44.97 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.4735 mL | 12.3674 mL | 24.7347 mL |
5 mM | 0.4947 mL | 2.4735 mL | 4.9469 mL |
10 mM | 0.2473 mL | 1.2367 mL | 2.4735 mL |
Add each solvent one by one: PBS
Solubility: 25 mg/mL (61.84 mM); Clear solution; Need ultrasonic and warming